Dynamix Corporation (NASDAQ:DYNXU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “DYNXU”, Thursday, November 21, 2024.
The new SPAC intends to focus its search on companies that are within the energy transition, oil and gas, and power sectors.
Dynamix Corporation is led by Chief Executive Officer and Chairman Andrea Bernatova, Chief Financial Officer Nader Daylami, and Vice President, M&A and Strategy Philip Rajan.
Diaco Aviki, Tyler Crabtree, and Lynn A. Peterson will serve on its Board of Directors.
Total SPAC deal count for 2024 year-to-date is now 48. This offering is expected to close on Friday, November 22, 2024.
The offering is being led by Cohen & Company Capital Markets as the lead book-running manager and Seaport Global Securities as joint book runner. Clear Street LLC is acting as co-manager for the offering. Gibson, Dunn & Crutcher LLP is serving as Issuer’s Counsel with Vinson & Elkins L.L.P. serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Odyssey Transfer and Trust Company is acting as trustee.
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...
In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...
An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...